Skip to content

daVinci Digital Therapeutics

  • Home
  • DTx Blog
  • DTx Newsletter
  • News
  • Pipeline
  • Events
  • DTxDay20
  • Contact us
  • Home
  • DTx Blog
  • DTx Newsletter
  • News
  • Pipeline
  • Events
  • DTxDay20
  • Contact us

daVinci Digital Therapeutics

a Digital Biotech Company

Monthly Archive: June 2020

Programmable Medicines and Digital Biotechnology

Digital Health

8 June 2020

 by daVinciDTx · Published 8 June 2020

Programmable Medicines and Digital Biotechnology

organized by daVinci Digital Therapeutics, Milan in collaboration with Argon Global Healthcare, LondonA EUROPEAN BIOTECH WEEK 2020 Webinar, 28 September 2020 Program to be published shortly

Recent Posts

  • White paper reveals pathway for digital therapeutics use in Italy
  • Digital Therapeutics, an Opportunity for Italy
  • Digital Therapeutics Day 2020 – Where Are We Now? We Are We Going?
  • Startup – Corporate collaboration to develop DTx
  • What are DTx Digital Excipients?
  • The New Era of Programmable Medicines
  • Programmable Medicines and Digital Biotechnology
  • Digital Therapeutics – What They Are, What They Will Be
  • Digital Therapeutic to Treat Adjustment Disorders during COVID-19
  • FDA has approved Somryst, a Digital Therapeutic to treat chronic insomnia
  • Research & Development of Digital Therapeutics

daVinci Digital Therapeutics
Via Giovanni Durando 38
20158 Milan – I
+ 39 02 2399 2985
https://davincidtx.com

Digital Therapeutics Day 2020 #DTxDAY20

https://www.youtube.com/watch?v=LVLd8gkuZuo&list=PLZQ1y6mMVircvV7EwcK4vLLHM0vW9r6Br&index=1&t=45s

ARCHIVES

  • February 2021
  • January 2021
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020

CATEGORIES

  • COVID-19
  • Digital Health
  • R&D
  • Research

Partnerships

Privacy Policy

Code of Ethics

daVinci Digital Therapeutics srl, Milan 2020